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Summary
 
The mechanism by which progesterone causes localized suppression of the immune response
during pregnancy has remained elusive. Using human T lymphocytes and T cell lines, we show
that progesterone, at concentrations found in the placenta, rapidly and reversibly blocks volt-
age-gated and calcium-activated K
 
1
 
 channels (K
 
V
 
 and K
 
Ca
 
, respectively), resulting in depolar-
ization of the membrane potential. As a result, Ca
 
2
 
1
 
 signaling and nuclear factor of activated T
cells (NF-AT)-driven gene expression are inhibited. Progesterone acts distally to the initial
steps of T cell receptor (TCR)-mediated signal transduction, since it blocks sustained Ca
 
2
 
1
 
 sig-
nals after thapsigargin stimulation, as well as oscillatory Ca
 
2
 
1
 
 signals, but not the Ca
 
2
 
1
 
 transient
after TCR stimulation. K
 
1
 
 channel blockade by progesterone is specific; other steroid hor-
mones had little or no effect, although the progesterone antagonist RU 486 also blocked K
 
V
 
and K
 
Ca
 
 channels. Progesterone effectively blocked a broad spectrum of K
 
1
 
 channels, reducing
both Kv1.3 and charybdotoxin–resistant components of K
 
V
 
 current and K
 
Ca
 
 current in T cells,
as well as blocking several cloned K
 
V
 
 channels expressed in cell lines. Progesterone had little or
no effect on a cloned voltage-gated Na
 
1
 
 channel, an inward rectifier K
 
1
 
 channel, or on lym-
phocyte Ca
 
2
 
1
 
 and Cl
 
2
 
 channels. We propose that direct inhibition of K
 
1
 
 channels in T cells by
progesterone contributes to progesterone-induced immunosuppression.
Key words: T lymphocyte • K
 
1
 
 channel • calcium signaling • gene expression • nuclear factor 
of activated T cells
 
I
 
mmunosuppression within the uterus is crucial for the
survival of the fetus (1, 2). Although the maternal im-
mune system becomes sensitized to paternal antigens dur-
ing pregnancy, fetal cells and placental trophoblasts bearing
those antigens do not elicit a cytolytic immune response
(3–5). High concentrations of progesterone in the placenta
inhibit the maternal immune response against the fetal al-
lograft (6, 7). The immunosuppressive effects of progester-
one were demonstrated in vivo by prolonged survival of xe-
nografts near silastic implants containing progesterone at
concentrations typically found in the placenta (3, 6). In vitro
assays have established that progesterone inhibits lympho-
cyte activation and proliferation in response to allogeneic
cells or mitogens (8–10). In contrast, progesterone does not
inhibit the effector functions of previously activated cy-
tolytic T cells (11). These data suggest that progesterone
may interfere with the early phases of T cell activation.
Antigen presentation and TCR ligation stimulate ty-
rosine kinases, leading to the generation of inositol 1,4,5-
trisphosphate (IP
 
3
 
)
 
1
 
 and a consequent rise in the cyto-
plasmic calcium concentration ([Ca
 
2
 
1
 
]
 
i
 
). Elevated [Ca
 
2
 
1
 
]
 
i
 
activates calcineurin, a phosphatase which then dephosphor-
ylates a cytoplasmic transcription factor, the nuclear factor
of activated T cells (NF-AT). Dephosphorylated NF-AT
moves into the nucleus where it promotes the expression
of the IL-2 gene (12). A sustained elevation in [Ca
 
2
 
1
 
]
 
i
 
 re-
quiring Ca
 
2
 
1
 
 influx across the plasma membrane is neces-
sary for the retention of NF-AT in the nucleus and effi-
cient transcription of IL-2 (13–16). In lymphocytes, the
opening of Ca
 
2
 
1
 
 release–activated Ca
 
2
 
1
 
 (CRAC) channels
initiates Ca
 
2
 
1
 
 influx after the depletion of Ca
 
2
 
1
 
 stores by
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Abbreviations used in this paper:
 
 [Ca
 
2
 
1
 
]
 
i
 
, intracellular free calcium concen-
tration; CRAC, Ca
 
2
 
1
 
 release–activated Ca
 
2
 
1
 
; CTX, charybdotoxin; 
 
E
 
m
 
,
membrane potential; IP
 
3
 
, inositol 1,4,5-trisphosphate; K
 
Ca
 
, Ca
 
2
 
1
 
-activated
K
 
1
 
; K
 
V
 
, voltage-gated K
 
1
 
; NF-AT, nuclear factor of activated T cells;
TG, thapsigargin.
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IP
 
3
 
 (17–19). Once the CRAC channels are open, the trans-
membrane concentration gradient for Ca
 
2
 
1
 
 and the mem-
brane potential (
 
E
 
m
 
) provide the driving force for Ca
 
2
 
1
 
entry. 
 
E
 
m
 
 is set by the interplay between several ion channels
in the T cell membrane. By itself, the Ca
 
2
 
1
 
 current through
CRAC channels would diminish the driving force for cal-
cium entry by reducing 
 
E
 
m
 
. However, currents through
voltage-gated K
 
1
 
 (K
 
V
 
) channels and Ca
 
2
 
1
 
-activated K
 
1
 
 (K
 
Ca
 
)
channels enhance Ca
 
2
 
1
 
 entry by driving 
 
E
 
m
 
 to a negative
voltage. Chloride channels may also play a role in maintain-
ing a negative 
 
E
 
m
 
 during T cell activation (20, 21). The four
major types of ion channels found in T cells are possible tar-
gets for immunosuppressive agents. In particular, the K
 
V
 
channel encoded by Kv1.3 is required for normal lympho-
cyte activation both in vitro and in vivo (14, 22–25).
We have determined the effects of progesterone on lym-
phocyte ion channels, Ca
 
2
 
1
 
 signaling, and gene expression.
By combining functional assays of gene expression with
patch-clamp and Ca
 
2
 
1
 
-imaging measurements, we demon-
strate that progesterone blocks lymphocyte K
 
1
 
 channels,
interferes with TCR-induced [Ca
 
2
 
1
 
]
 
i
 
 signaling, and inhib-
its gene expression. We propose that progesterone acts as
an endogenous immunosuppressant by directly and revers-
ibly blocking K
 
1
 
 channels.
 
Materials and Methods
 
Chemicals and Solutions.
 
Salts and other reagents were ob-
tained from Sigma Chemical Co. (St Louis, MO) unless other-
wise noted. Thapsigargin (TG) was obtained from Alexis Corp.
(San Diego, CA). Progesterone (10 mM) and PMA (3 mM)
stocks were prepared in DMSO.
 
Cell Culture.
 
B3Z cells and K897 cells were provided along
with the antigenic peptide fragment SIINFEKL by Dr. N. Shastri
(University of California, Berkeley, CA). B3Z cells are a murine,
CD8
 
1
 
, T cell hybridoma with a known antigen specificity for
OVA/K
 
b
 
-MHC and containing a 
 
b
 
-galactosidase reporter gene
construct (
 
lacZ
 
) under the control of the NF-AT promoter (26).
The corresponding antigen-presenting K897 cells had been trans-
fected with K
 
b
 
 class I MHC as described (27). The human leuke-
mia T cell line Jurkat E6-1 was obtained from the American
Type Culture Collection (Rockville, MD). Human peripheral T
lymphocytes were collected from venous blood of healthy volun-
teers and isolated using a Ficoll-Hypaque density gradient as de-
scribed previously (28). A population of activated T cell blasts was
prepared in culture by treating the resting cells with 10 
 
m
 
g/ml
PHA (PHA-P; Difco Laboratories, Inc., Detroit, MI). Cell lines
expressing the cloned K
 
V
 
 channels Kv1.1, Kv1.2, Kv1.3, Kv1.4,
Kv1.5, and Kv3.1 and a voltage-gated Na
 
1
 
 channel hSKM1 were
maintained in culture. All cells were grown in RPMI 1640 me-
dium containing 10% heat-inactivated fetal bovine serum, 10 mM
Hepes, 2 mM glutamine, 1 mM pyruvate, 50 
 
m
 
M 2-ME. Cells
were cultured in 25-ml flasks (Costar Corp., Cambridge, MA) at
37
 
8
 
C, 5% CO
 
2
 
 in a humidified incubator. For experiments on in-
ward rectifier K
 
1
 
 channels, rat basophilic leukemia (RBL) cells
were maintained in Eagle’s MEM supplemented with 10% FCS
and 1% 
 
l
 
-glutamine. RBL cells were plated onto glass coverslips
1–2 d before use.
 
LacZ Reporter Gene Assay.
 
The fraction of B3Z cells express-
ing 
 
b
 
-galactosidase was measured using flow cytometry (FAC-
Scan
 
Ò
 
; Becton Dickinson, San Jose, CA) as described previously
(13). In brief, 5 
 
3
 
 10
 
4
 
 cells in RPMI without serum were placed
in individual wells of 24-well plates activated either by 1 
 
m
 
M TG
plus 50 nM PMA or by antibodies to the CD3-
 
e
 
 subunit of the
TCR complex. In the latter, wells were coated with 10 
 
m
 
g/ml
anti–CD3-
 
e
 
 antibodies (PharMingen, San Diego, CA) overnight
and rinsed briefly with PBS before use. Cells were activated in
the incubator for a total of 4 h before being resuspended and
loaded by osmotic shock with the fluorogenic substrate, fluores-
cein-di-
 
b
 
-galactopyranoside (FDG; Molecular Probes, Inc., Eu-
gene, OR). The fluorescence of 
 
lacZ
 
1
 
 cells was at least fivefold
greater than autofluorescence. The effect of progesterone on 
 
lacZ
 
gene expression was quantified using a MUG (4-methylumbel-
liferyl 
 
b
 
-
 
d
 
-galactopyranoside) assay (29). In brief, B3Z cells were
plated at 10
 
5
 
 cells per well in 96-well plates, and the fluorescence
produced by cell lysates in a solution containing 3 mM MUG was
measured in a multi-well plate reader (CytoFluor Series 4000;
PerSeptive Biosystems, Framingham, MA).
 
Patch-clamp Recordings.
 
Membrane currents were measured
using the whole-cell configuration of the patch-clamp technique
(28, 30), and membrane potential was measured using the perfo-
rated patch method in current-clamp mode with nystatin to per-
meabilize the cells (31). An EPC-9 amplifier (HEKA, Lambrecht/
Pfalz, Germany) interfaced to a Macintosh Quadra 700 computer
was used for pulse application and data recording. Membrane
voltages were corrected for liquid junction potentials, and current
recordings were corrected for leak and capacitative currents.
Patch pipettes were pulled from Accu-fill 90 Micropets (Becton
Dickinson, Parsippany, NJ) using a P87 micropipette puller (Sut-
ter Instruments Co., Novato, CA). Pipettes were coated with
Sylgard (Dow Corning Corp., Midland, MI) and heat polished
to final resistances of 2–5 M
 
V
 
. Patch-clamp experiments were
performed at room temperature (20–25
 
8C). Unless otherwise in-
dicated, the membrane currents were filtered at 1.5 kHz. Data
analysis was performed using the program Pulse (HEKA). Mam-
malian Ringer contained (in mM): 160 NaCl, 4.5 KCl, 2 CaCl2,
1 MgCl2, 10 Hepes (pH 7.4; osmolality 290–310 mosmol/kg).
The ionic composition of the pipette solutions used in the indi-
vidual experiments is reported in the figure legends.
[Ca21]i Measurement. [Ca21]i was measured ratiometrically
using fura-2, as described previously (13). In brief, cells were
loaded with 3 mM fura-2/AM (Molecular Probes, Inc.) for 30–40
min at room temperature (20–258C). The cells were then washed
three times with RPMI/10% FCS and stored in the dark. Illumi-
nation was provided by a xenon arc-lamp (Carl Zeiss, Jena, Ger-
many) and transmitted through a filter wheel unit (Lambda 10;
Axon Instruments, Inc., Foster City, CA) containing 350- and
385-nm excitation filters. The filtered light was reflected by a
400-nm dichroic mirror through a 633 oil-immersion objective
to illuminate cells. Emitted light .480 nm was received by a SIT
camera (C2400; Hamamatsu Photonics, Bridgewater, NJ) and the
video information relayed to an image processing system
(Videoprobe; ETM Systems, Petaluma, CA). Full field-of-view
8-bit images, averaged over 16 frames, were collected at 350- and
385-nm wavelengths. Digitally stored 350/385 ratios were con-
structed from background-corrected 350- and 385-nm images.
Single-cell measurements of [Ca21]i were calculated from the
350/385 ratios using the equation of Grynkiewicz et al. (32) and
a Kd of 250 nM for fura-2. The minimum 350/385 ratio was
measured in single cells after incubation for 10 min in Ca21-free
Ringer containing 2 mM EGTA. Maximum ratio values were
obtained after perfusion with Ringer containing 10 mM Ca21, 1 mM
TG, and 10 mM ionomycin.1595 Ehring et al.
Figure 1. Progesterone inhibits NF-AT–
mediated gene expression in B3Z cells. (A)
The concentration-dependent inhibition of
lacZ expression in B3Z cells by progesterone
(d) or RU 486 (h) was measured in a multi-
well fluorescence plate reader using MUG as a
substrate for b-galactosidase. The cells were
stimulated for 4 h with 1 mM TG plus 50 nM
PMA. For each experiment, triplicate samples
were corrected for background fluorescence
and normalized for control lacZ expression.
Data are presented as mean 6 SD (n 5 10),
and were fitted to a Hill equation of the form
y
ymax
1 X []
IC50
----------- èø
æö
n
+
------------------------------ ,  =
where y 5 the fraction of control lacZ expression with a maximum level represented by ymax, [X] 5 the concentration of progesterone, IC50 5 the dissocia-
tion constant, and n 5 the Hill coefficient. The curve represents a Hill equation with an IC50 value of 22 6 2.1 mM and n 5 1.7 6 0.3. The effects of
progesterone were not due to nonspecific toxicity, since after treatment with 30 mM progesterone, .95% of the cells stained with vital stain acetoxy-meth-
oxy calcein and ,5% stained with propidium iodide, a dye that is excluded from live cells. (B) Application of 30 mM progesterone reduced lacZ expression
when B3Z cells were stimulated for 4 h by 1 mM TG alone, a combination of 1 mM TG plus 50 nM PMA (TG 1 PMA), immobilized anti–CD3-e anti-
bodies, or K897 cells presenting SIINFEKL. Fluorescence readouts from the multiwell plate reader in arbitrary units (a.u.) are presented as mean 6 SD (white
bars, stimulation alone; hatched bars, stimulation plus 30 mM progesterone). *Significance was determined with one-tail t tests (P , 0.0001).
Data Analysis. Numerical values for single-cell [Ca21]i traces
were analyzed with Origin (Microcal Software, Inc., Northamp-
ton, MA). Statistical analysis was performed on data sets using
Excel version 5.0 (Microsoft Corp., Redmond, WA). Data are
reported as mean 6 SD. Analysis of variance (ANOVA) or Stu-
dent’s t test was used to compare mean values. Pairs of means
were considered statistically different if P , 0.05.
Results
Progesterone Suppresses Gene Expression Driven by NF-AT.
The murine T cell hybridoma, B3Z, recognizes an oc-
tapeptide fragment from ovalbumin (SIINFEKL) and ex-
presses the lacZ reporter construct under transcriptional
control of the NF-AT response element of the IL-2 pro-
moter (26, 27). Several treatments that increase [Ca21]i lead
to NF-AT–driven lacZ expression in B3Z cells (13),
including TCR engagement or stimulation with TG, a
specific inhibitor of the endoplasmic reticulum Ca21-
ATPase (33). By flow cytometry in the present series of ex-
periments, cross-linking the TCR with anti–CD3-e anti-
bodies or stimulating with TG plus PMA produced lacZ
expression in the majority of B3Z cells (60 6 4%, n 5 7; or
72 6 10%, n 5 3, respectively). Progesterone reduced NF-
AT–mediated  lacZ gene expression in a concentration-
dependent manner, with an IC50 value of 22 6 2.1 mM in
cells stimulated by TG/PMA (Fig. 1 A, filled circles). The
progesterone antagonist RU 486 also inhibited gene ex-
pression with slightly lower potency (Fig. 1 A, open
squares). Progesterone reduced lacZ expression when B3Z
cells were stimulated by TG alone or with PMA, by immo-
bilized anti–CD3-e antibody, or by antigen presentation
(Fig. 1 B). Thus, at concentrations normally obtained in the
placenta (34, 35), progesterone inhibits NF-AT–mediated
gene expression when driven by four treatments that in-
crease [Ca21]i. Our results with NF-AT–driven lacZ re-
porter gene expression are consistent with levels of proges-
terone or RU 486 shown previously to inhibit activation of
human T cells in vitro (8, 9).
Progesterone Inhibits [Ca21]i Signals in T Cells after TCR
Engagement or TG Stimulation. Upon contact with K897
cells preloaded with SIINFEKL, B3Z cells responded with an
initial Ca21 transient from a resting [Ca21]i of 180 6 86 nM
to a peak of 2.5 6 0.5 mM (n 5 20), followed by sustained
Ca21 oscillations (Fig. 2 A). In the absence of preloaded anti-
gen, K897 cells did not elicit Ca21 signaling in B3Z cells (data
not shown). Application of 50 mM progesterone reversibly
suppressed antigen-induced Ca21 oscillations (Fig. 2 A).
To determine if progesterone directly inhibits TCR-ini-
tiated signaling or interferes with costimulatory pathways,
we activated the TCR complex by cross-linking CD3. Set-
tling B3Z cells onto chambers coated with anti–CD3-e an-
tibodies elicited an initial Ca21 transient followed by vigor-
ous Ca21 oscillations that continued for at least 40 min
(Fig. 2 B). In the presence of 50 mM progesterone, most
cells produced only the initial Ca21 transient lasting 271 6
178 s, or a transient followed by severely attenuated oscilla-
tions (n 5 14; Fig. 2 C). These data demonstrate that
progesterone blocks Ca21 signaling after TCR engage-
ment. Since the initial Ca21 transient results from IP3-
mediated release of Ca21 from intracellular stores, and the
sustained Ca21 signal requires Ca21 influx, these data also
suggest that progesterone inhibits Ca21 influx but not the
steps that lead to Ca21 release from intracellular stores.
TG inhibits the Ca21 reuptake pump, leading to deple-
tion of the intracellular Ca21 stores and Ca21 influx while
bypassing the initial steps of TCR signaling and IP3 genera-
tion (36, 37). In resting human T cells, the addition of TG
to the bathing solution increased [Ca21]i from 72 6 8 nM
to a stable plateau level of 1.2 6 0.1 mM (n 5 76; Fig. 3
A). Progesterone reversibly inhibited the sustained Ca21
signal with an IC50 value of 28 6 2.7 mM (Fig. 3, A and1596 Progesterone Blocks K1 Channels and T Cell Activation
B). Thus, progesterone blocks Ca21 influx subsequent to
emptying of the Ca21 stores.
Progesterone Depolarizes the Membrane Potential, Reducing
the Driving Force for Ca21 Entry. Ca21 influx depends upon
the opening of CRAC channels and upon an electrochem-
ical gradient for Ca21 entry across the cell membrane. The
negative membrane potential supported by K1 channels
provides the electrical component of the driving force fa-
voring Ca21 entry; membrane depolarization would reduce
this driving force. By direct measurement during perforated-
patch current-clamp recording, we found that progesterone
depolarizes the membrane potential, Em. KV channels
normally maintain the resting membrane potential of T
lymphocytes near 260 mV (38). Fig. 4 A illustrates that
membrane hyperpolarization accompanies TG stimulation
(from 261 6 1.2 mV, n 5 3; to 278 6 2.0 mV, n 5 11).
The hyperpolarization that follows TG stimulation is pro-
duced by activation of KCa channels during the rise in
[Ca21]i, driving Em towards the K1 equilibrium potential of
z280 mV. Progesterone (50 mM; application bar, Fig. 4 A)
not only reversed the hyperpolarization, but also resulted in
depolarization to an average of 241 6 4.3 mV (n 5 13,
P , 0.0001). These results suggest that progesterone may
block both KV and KCa channels. If the reduction of [Ca21]i
by progesterone is secondary to decreased K1 current, then
restoration of a K1 flux across the cell membrane should
reverse this effect of progesterone. We tested this hypothe-
sis by using the K1 ionophore, valinomycin, to hyperpolar-
ize  Em. In the experiment shown in Fig. 4 B, 30 mM
progesterone reduced the plateau in [Ca21]i that followed
TG stimulation. The subsequent addition of valinomycin
in the continued presence of progesterone resulted in an
increase of [Ca21]i. Thus, Ca21-imaging and current-clamp
experiments demonstrate that progesterone reduces the
driving force for Ca21 entry, an effect that can be reversed
by reestablishing K1 efflux. These data suggest that proges-
terone may affect [Ca21]i and gene expression by blocking
K1 channels.
Progesterone Blocks Voltage-gated K1 and Ca21-activated K1
Channels in T Cells. Whole-cell recording with the patch-
clamp technique permits direct measurement of several
types of channel activity in T cells. A voltage step from a
holding potential of 280 to 130 mV elicits rapidly activat-
ing KV currents, which reach a peak and then slowly inacti-
vate. KV currents consist of two components, a predominant
fraction encoded by homotetramers of the Shaker-related
Kv1.3 gene and a much smaller fraction of unknown
molecular identity (for a review, see reference 24). The
two components can be readily distinguished by their bio-
physical and pharmacological properties. Kv1.3 channels
are blocked by nanomolar concentrations of a scorpion
toxin, charybdotoxin (CTX), and undergo cumulative
(use-dependent) C-type inactivation during repetitive de-
polarization. The smaller, CTX-resistant current does not
exhibit use-dependent inactivation. Application of proges-
terone rapidly and reversibly reduces KV currents in human
or B3Z T cells, with an IC50 of 29 6 2 mM for the peak
K1 current (Fig. 5). Progesterone accelerates the decline of
K1 current during a depolarizing pulse, and thus the block
Figure 2. Progesterone inhibits [Ca21]i oscillations induced by TCR li-
gation. (A) [Ca21]i responses from four representative B3Z cells activated
by contact with SIINFEKL-presenting K897 cells illustrate that [Ca21]i
oscillations were reversibly inhibited by the application of 50 mM proges-
terone to the bath (bar). (B) [Ca21]i oscillations in four B3Z cells activated
by settling onto coverslips coated with anti–CD3-e antibodies in the ab-
sence (a) or presence (b) of 50 mM progesterone.
Figure 3. Progesterone reduces the [Ca21]i
plateau evoked by TG stimulation in human
T cells. (A) Average [Ca21]i is plotted against
time (n 5 76) before and during stimulation
with 1 mM TG (arrow). TG stimulated Ca21
influx, resulting in a stable rise in [Ca21]i. Ad-
dition of 30 mM progesterone (bar) reversibly
reduced the [Ca21]i plateau obtained after TG
stimulation. (B) The concentration depen-
dence of the reduction of [Ca21]i by proges-
terone is plotted for TG-stimulated cells. Cal-
cium levels were normalized by subtracting
the resting [Ca21]i and dividing [Ca21]i in the
presence of progesterone and TG by [Ca21]i
in the presence of TG alone. Data are pre-
sented as mean 6 SD and were fitted to a Hill
equation illustrated by the smooth curve
(IC50  5 28 6 2.7 mM and n 5 1.3 6 0.2).1597 Ehring et al.
is more potent when evaluated at the end of a 200-ms pulse
(Fig. 5 C, filled triangles). The apparent increased rate of
channel inactivation (Fig. 5, A and B) suggests that proges-
terone may preferentially bind to and block the open or
inactivated Kv1.3 channel. To determine if steady-state in-
activation enhances the block by progesterone, we inacti-
vated a significant fraction of Kv1.3 channels by decreasing
the holding potential from 280 to 250 mV. As shown in
Fig. 6 A, progesterone (30 mM) reduced the peak Kv1.3
currents more potently when the holding potential was
250 mV (70% block; see open circle in Fig. 5 C) than when
the holding potential was 280 mV (45% block), demon-
strating that channel inactivation effectively enhances the
block of Kv1.3 currents by progesterone. During antigen-
induced oscillations of [Ca21]i, Kv1.3 channels would un-
dergo repetitive cycles of activation, inactivation, and recov-
ery as the membrane potential fluctuates. Activation cycles
can result in frequency or use-dependent inhibition if the in-
terval between depolarizations is less than the time required
for full recovery from inactivation; normally, pulse intervals
of .20 s allow full recovery. In the presence of progester-
one, Kv1.3 currents steadily declined during repetitive
pulsing, because channel inactivation recovers 10-fold
more slowly, resulting in accumulation of channels in the
inactivated state (Fig. 6, B and C).
We also examined the effects of progesterone on the
smaller component of KV current by selectively blocking
the Kv1.3 component with 100 nM CTX. At this dose, we
expect a residual Kv1.3 current of only 2% that in the ab-
Figure 4. Progesterone re-
duces the driving force for Ca21
influx. (A) Current-clamp re-
cordings using the perforated-
patch technique were performed
in B3Z cells to determine the
effects of progesterone on Em.
This panel presents a representa-
tive single-cell recording. The
addition of 1 mM TG (arrow) hy-
perpolarized the cell from the
resting potential (260 mV) to
near the K1 equilibrium poten-
tial (z280 mV), enhancing the
driving force for Ca21 influx.
Subsequent application of 50
mM progesterone depolarized
the cell to 226 mV, resulting in
a reduction of the driving force
for Ca21 influx. For perforated-
patch recordings, the tips of the
pipettes were filled with the following solution (in mM): 120 K2SO4, 16
KCl, 5 MgSO4, 10 Hepes (pH 7.2). A stock solution of nystatin in
DMSO (25 mg/ml) was prepared daily and subsequently diluted in the pi-
pette solution to a final concentration of 100 mg/ml. After sonication, this
solution was used for backfilling the pipettes as described previously (ref-
erence 31). (B) Measurements of average [Ca21]i from B3Z cells (n 5 37).
After the addition of 1 mM TG (arrow), [Ca21]i rose from a resting level of
70 6 30 nM to a plateau of 1.3 6 0.4 mM. Progesterone (30 mM) re-
duced the [Ca21]i to approximately half of plateau concentration, an effect
that was completely reversed by the addition of 2 mM valinomycin. Ap-
plication bars, The additions of progesterone and valinomycin to the bath.
Figure 5. Progesterone blocks KV channels. Whole-
cell currents were measured in human T cells (A) and
B3Z cells (B) during 200-ms voltage pulses from a
holding potential of 280 mV to 130 mV applied ev-
ery 30 s. The pipette solution contained (in mM):
160 K1 aspartate, 2 MgCl2, 1 CaCl2, 10 EGTA, 10
Hepes (pH 7.2). Currents are shown before and dur-
ing bath application of 10, 30, or 100 mM progester-
one. (C) Concentration dependence for the reduc-
tion of KV currents by progesterone. Peak current
amplitudes in human T cells (n) and B3Z cells (h)
were analyzed and plotted against progesterone con-
centration. Data points for B3Z and human T cells
overlie each other at most concentrations. For human
T cells, the current at the end of the 200-ms pulse (m) was also plotted. To determine the effect of depolarization on progesterone block, Em was held at
250 mV (s). Data were normalized to control currents measured in the absence of progesterone and presented as mean 6 SD. The line represents a fit
using a Hill equation with an IC50 of 29 6 2 mM and n 5 2.1 6 0.4.
Figure 6. Inactivation enhances
KV block by progesterone. (A)
KV currents were elicited by
steps to 130 mV from holding
potential of 280 mV (1, 3) or
250 mV (2, 4) in the absence (1,
2) or presence (3, 4) of 30 mM
progesterone. Solutions used are
as in Fig. 5. (B) Use-dependent
block of voltage-gated K1 cur-
rents. Current responses were
elicited by repetitive voltage
pulses from 280 to 130 mV
separated by 20 s. Normalized
peak current amplitudes in the
absence (j) or presence (.) of
67 mM progesterone were plot-
ted against time. (C) Time course
of recovery from inactivation in a
B3Z cell before and during appli-
cation of 60 mM progesterone.
Pairs of 200-ms pulses to 130
mV were applied from a holding
potential of 280 mV. The graph
shows the ratio of peak current
during the second pulse to the
peak current during the first
pulse, plotted as a function of the
time interval between the pulses.
Data were fitted by single expo-
nentials with time constants of 4 s
for control (j) and 39 s for
progesterone (.).1598 Progesterone Blocks K1 Channels and T Cell Activation
sence of CTX. However, in 11 cells examined in this series
of experiments and in previous work (21), 5–20% of the
KV current remains in the presence of CTX. This residual
CTX-resistant current does not undergo use-dependent in-
activation during repetitive depolarizing pulses (Fig. 7 A).
Fig. 7 B demonstrates that the larger, use-dependent,
CTX-sensitive component of KV current is blocked either
by progesterone or by RU 486. As shown in Fig. 7 C,
most of the CTX-resistant current is also blocked by 50
mM progesterone, whereas RU 486 at the same concentra-
tion is less effective. We conclude that progesterone blocks
both the predominant Kv1.3 component and the CTX-
resistant component of KV current in T cells, and that RU
486 blocks primarily the Kv1.3 component.
KCa channels hyperpolarize the membrane potential of T
cells during the [Ca21]i signal, effectively counteracting the
depolarizing effects of Ca21 influx. KCa channels are volt-
age-independent and highly sensitive to a rise in [Ca21]i,
with half-activation at z400 nM and a steep [Ca21]i de-
pendence, suggesting that at least four Ca21 ions must bind
to open the channel (for a review, see reference 24). Based
upon biophysical characterization and its expression in T
cells, it is likely that the KCa channel in T cells is encoded
by the gene hKCa4 (39). Intracellular dialysis of B3Z or ac-
tivated human T cells with solutions containing 1 mM
Ca21 activated a large K1 current that was evident in volt-
age ramps (Fig. 8 A). Progesterone blocked KCa channels
with an IC50 value of 113 6 9 mM (Fig. 8 B). Thus,
progesterone blocks the KV currents more potently than
the KCa currents in T cells. In contrast, the progesterone
antagonist RU 486 was consistently more potent than
progesterone in blocking KCa current (Fig. 8 C). These ex-
periments demonstrate some degree of selectivity of the
two components of KV current and the KCa current for
progesterone and RU 486.
Selectivity of Progesterone for KV Channels: Progesterone Does
Not Block CRAC or Chloride Channels in T Cells. The re-
sults from patch-clamp experiments suggested that proges-
terone, RU 486, and perhaps other steroid hormones
might block several K1 channel types, albeit with rather
low affinity. Therefore, we screened a panel of steroids on
the KV and KCa channels in T lymphocytes. Most of the
compounds tested either had no effect or were less effective
than progesterone in blocking KV or KCa currents (Table
1). In addition, we screened several channel types, includ-
ing both cloned and native channels expressed in a variety
of cell lines, for block by progesterone, as summarized in
Table 2. Progesterone blocks several Kv1 family members, Figure 7. Progesterone blocks CTX-resistant KV channels. Pipette solu-
tion as in Fig. 5. (A) Current responses of the total KV current (d) and the
CTX-resistant current (j) to repetitive voltage pulses from 280 to 130
mV separated by 1 s. At this rate of pulsing, Kv1.3 channels undergo cu-
mulative inactivation, as shown by normalized peak current amplitudes in
the absence of CTX (j). With 100 nM CTX present (d), the remaining
current does not decline during repetitive pulsing. (B) Progesterone or
RU 486 (50 mM) blocks the KV component. (C) Progesterone blocks the
CTX-resistant component of KV current more than RU 486. 100 nM
CTX was preapplied in Ringer in order to block Kv1.3 channels.
Figure 8. Concentration-depen-
dent inhibition of KCa current in
B3Z cells by progesterone. (A)
KCa currents were activated by
dialyzing the cell with a solution
containing (in mM) 140 K1 as-
partate, 2 MgCl2, 7.8 CaCl2, 10
EGTA, 5 Hepes (pH 7.2). The
nominal free Ca21 concentra-
tion of this solution was 1 mM,
assuming a dissociation constant
for EGTA and Ca21 of 1027 at
pH 7.2. Ca21-activated K1 cur-
rents were evoked by voltage
ramps of 200-ms duration from
2120 to 150 mV every 30 s.
Application of progesterone at
different concentrations (indi-
cated at the right of each trace)
inhibited the KCa current. (B) Concentration–response curve for pro-
gesterone block of KCa currents (d). The slope conductance between
2100 and 260 mV was used as a measure of the KCa conductance to
avoid contamination by KV currents. Data were normalized to the con-
ductance measured in the absence of progesterone and presented as
mean  6 SD. The line represents the fit to a Hill equation with IC50 5 113
mM and n 5 1.2. Block of KCa channels by 60 mM RU 486 (h) is shown
for comparison. (C) Comparison of progesterone and RU 486. Slope con-
ductance values at 280 mV illustrate activation and block of the KCa current
by RU 486 and progesterone, each applied at 60 mM.1599 Ehring et al.
including Kv1.3 expressed in lymphocytes as the predomi-
nant KV current, as well as Kv3.1 expressed in the brain and
in certain subsets of mouse thymocytes. In contrast, proges-
terone had very little effect on a cloned voltage-gated Na1
channel found in skeletal muscle, or on a strongly inward
rectifying K1 channel found in RBL cells. We conclude
that progesterone is a broad spectrum, low-affinity K1
channel blocker.
In further experiments on Jurkat T lymphocytes, we
evaluated effects of progesterone on CRAC and Cl2 chan-
nels to determine if modulation of these channel types
might contribute to the inhibition of Ca21 signaling. Dur-
ing whole-cell patch-clamp recordings, intracellular dialysis
with heavily buffered low-Ca21 solutions passively de-
pleted the intracellular Ca21 stores and activated CRAC
channels (Fig. 9 A). After maximal activation, 30 mM
progesterone (Fig. 9 B, application bar) had no effect on the
amplitude or the current-voltage characteristics (n 5 6
cells). This experiment rules out direct CRAC channel
block as a possible contributor to the inhibition of Ca21
signaling by progesterone; instead, it appears that progester-
one blocks Ca21 signaling by inhibiting K1 channels, indi-
rectly reducing the driving force for Ca21 entry. Cl2 chan-
nels have also been implicated in lymphocyte signaling
mechanisms by helping to maintain Em during T cell acti-
vation (20, 21). However, superfusion of B3Z or Jurkat
cells with 50 mM progesterone did not affect the amplitude
or the current-voltage characteristics of Cl2 currents in-
duced by cell swelling (Fig. 9, C and D).
Discussion
In this report, we demonstrate by patch-clamp measure-
ment that progesterone directly blocks KV and KCa chan-
nels, but not Ca21 or Cl2 channels in T lymphocytes. Fur-
thermore, we show that K1 channel blockade is associated
with membrane depolarization, inhibition of Ca21 signal-
ing, and a reduction of NF-AT–driven gene expression.
Since NF-AT links activation of the TCR to IL-2 produc-
tion, interruption of these signals would inhibit production
of the major proliferative cytokine for T cells. We propose
that K1 channel blockade provides a mechanism contribut-
ing to the immunosuppressive effects of progesterone.
The rapid onset and reversibility of KV channel block by
progesterone is incompatible with changes in mRNA or
protein synthesis, suggesting that these effects are not medi-
ated by the classical steroid receptor pathway (40). The
progesterone antagonist RU 486 is nearly as potent as
progesterone in blocking both KV channels and gene ex-
pression, also implicating a nongenomic action of proges-
Table 1. Percent Inhibition of KV and KCa Channels by Steroids (60 mM)
Progesterone RU 486 Estradiol Testosterone Cortisol DHEA OHP Aldosterone
KV 77 6 8 61 6 15 24 6 7 17 6 12 13 6 4 10 6 6 12 6 6 12 6 13
KCa 34 6 11 55 6 12 8 6 10 4 6 7 0.0 6 0.1 0.4 6 0.7 2 6 46  6  7
Currents through KV channels in human T cells were evoked by depolarizing pulses to 130 mV, as in Fig. 5. KCa channels in activated human T
cells were opened by 1 mM [Ca21]i, with currents measured during voltage-ramp stimuli as in Fig. 8. Data are presented as mean 6 SD, with at least
three separate experiments for each compound tested at 60 mM, and represent the percent inhibition of peak KV currents or slope conductances of
KCa currents near 280 mV. DHEA, Dehydroepiandrosterone; OHP, 17a-hydroxy-4-pregnene-3,20-dione.
Table 2. Percent Inhibition of Various Channel Types by Progesterone
Cloned channels
Gene Kv1.1 Kv1.2 Kv1.3 Kv1.4 Kv1.5 Kv3.1 hSKM1
Cell type L929 NGK1 L929 LTK MEL L929 HEK
31 6 64 5  6 10 44 6 9 23 6 8 25 6 2 53 6 3 11 6 1
Native channels
Channel KV KV KV (CTX) KCa CRAC Cl2 KIR
Cell type Human T B3Z Human T Human T, act. Jurkat T Jurkat T RBL
50 6 6 40 6 10 70 6 20 34 6 11 0 0 4 6 12
The panel of cloned KV channels was provided by Dr. K. George Chandy (Department of Physiology and Biophysics, University of California, Irvine), as
described (reference 55). The voltage-gated Na1 channel clone hSKM1, originally derived from skeletal muscle, was made by Dr. Frank Lehmann-Horn
(Department of General Physiology, University of Ulm, Germany). Peak Na1 currents were evaluated at 110 mV. KV currents were evoked by de-
polarizing pulses, as in Fig. 5. CTX-resistant KV channels [KV (CTX)] were studied in the presence of 100 nM CTX, as in Fig. 7. KCa channels were
activated by 1 mM [Ca21]i, as in Fig. 8. CRAC and Cl2 channels were activated by Ca21-store depletion or by cell swelling, respectively, as in Fig.
9. Inwardly rectifying K1 (KIR) currents were evaluated during voltage-ramp stimuli. In each case, progesterone was tested at 30 mM, except for KV
(CTX), KCa, and Cl2 channels tested at 50 mM. Data are presented as mean 6 SD, with at least three separate experiments for each channel type.1600 Progesterone Blocks K1 Channels and T Cell Activation
terone. Furthermore, channel inactivation enhances block
by progesterone, suggesting that the state of the channel
modulates the affinity of progesterone. In T cells, the direct
block of KV channels by dihydroquinolines and benzhydryl
piperidines is also enhanced by inactivation (41, 42). In ad-
dition, progesterone blocks Kv1.3 channels exogenously
expressed in a cell line (Table 2). Progesterone also blocks
other KV and KCa channels with low affinity. These data
suggest that progesterone blocks K1 channels directly,
rather than acting via the classical nuclear progesterone re-
ceptor pathway.
Channel blockade by progesterone is not without prece-
dent. Previous studies demonstrated that progesterone
blocks voltage-gated Ca21 channels in smooth muscle cells
and a variety of K1 channels in MDCK cells and hepato-
cytes (43–45). Several transmitter-activated channels are
also suppressed by progesterone in the micromolar concen-
tration range (46–49). In contrast to its effects on somatic
cells, progesterone activates Ca21 influx in sperm (50, 51).
We found no evidence for progesterone-induced Ca21 in-
flux in T cells.
Our data provide the first evidence that an endogenous
hormone may act as an immunosuppressant by blocking
K1 channels. Inhibition of K1 channels has been shown to
reduce IL-2 production and T cell activation in vitro (22,
23, 52). Moreover, recent studies demonstrated that the
peptide scorpion toxin margatoxin, a specific blocker of
Kv1.3 channels, inhibits delayed-type hypersensitivity reac-
tion and reduces response to allogeneic challenge in vivo
(25). The depolarization and reduction of the driving force
for Ca21 entry resulting from K1 channel inhibition are
sufficient to account for the reduction of Ca21 signals and
NF-AT–driven gene expression. CRAC channels are in-
wardly rectifying, and a modest depolarization can reduce
Ca21 entry significantly, reducing the rise in [Ca21]i below
the threshold for gene expression (for a review, see refer-
ence 24). At high concentrations, progesterone reduces
Ca21 signaling and gene expression almost to control levels,
below a plateau level seen with 100 nM CTX (21, 53, and
data not shown). Progesterone, although acting with low
affinity, may reduce Ca21 signaling and gene expression to
a greater extent than CTX because progesterone also
inhibits CTX-resistant KV channels. The block of K1
channels by progesterone or RU 486 can also account for
previous results showing that progesterone or RU 486 in-
hibits activation of human T cells in vitro (8, 9), as well as
the reduction of the number of CD31 cells in the placenta
compared with maternal blood (11, 54).
During pregnancy, immunoregulatory mechanisms must
operate locally at the placental interface and be readily re-
versible to preserve the systemic immune competence of
the mother. Several mechanisms involving progesterone
may contribute to fetal–maternal protection, including al-
tered expression of MHC class I proteins in fetal tissue, al-
tered T cell subsets, or elaboration of immunosuppressive
factors (2). Biochemical measurements have estimated
progesterone concentrations to be 20 mM within the pla-
centa (34, 35); concentrations in the vicinity of trophoblasts
producing progesterone must be even higher. Average
progesterone levels found in the placenta would be suffi-
cient to block lymphocyte K1 channels and thereby medi-
ate a highly localized and reversible immunosuppression
without compromising the maternal immune system. The
affinity of progesterone for K1 channels ensures that this
mechanism would only be effective in the region of poten-
tial contact between allogeneic cells, where progesterone is
present at high concentrations.
Figure 9. Progesterone does not affect CRAC or Cl2 channels. (A)
Whole-cell recordings of Ca21 current through CRAC channels mea-
sured during voltage ramps from 2100 to 140 mV for a duration of 200
ms. The pipette solution contained (in mM) 128 Cs1 aspartate, 12
BAPTA, 0.9 CaCl2, 3.16 MgCl2, Hepes (pH 7.2). The external solution
had the following composition (in mM): 150 NaMeSO3, 20 CaCl2, 10
glucose, 10 Hepes (pH 7.4). (B) Time-dependent changes in the ampli-
tude of the current measured at 280 mV. Arrows, Representative currents
recorded before store depletion (1), and after maximal induction activa-
tion of CRAC channels, while superfusing cells with control solution (2)
or with an external solution containing 30 mM progesterone (3). (C)
Whole-cell recordings of swelling-activated Cl2 current (ICl) measured
during voltage ramps from 2120 to 140 mV for a duration of 200 ms.
The pipette solution contained (in mM) 140 Cs1 aspartate, 2 MgCl2, 4
MgATP, 1 CaCl2, 10 EGTA, 10 Hepes (pH 7.2). For the induction of
ICl, the pipette solution was made hypertonic (390–400 mosmol) by the
addition of 100 mM glucose. Currents are shown before the onset of cell
swelling (1), and after maximal induction of ICl, while superfusing cells
with control solution (2) or with an external solution containing 50 mM
progesterone (3). (D) Time-dependent changes in the slope conductance
measured at the reversal potential for Cl2.1601 Ehring et al.
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